|
Volumn 51, Issue 4, 2016, Pages 372-378
|
One-year safety and efficacy of tobramycin powder for inhalation in patients with cystic fibrosis
|
Author keywords
Cystic fibrosis; forced expiratory volume in one second; long term safety; Pseudomonas aeruginosa; tobramycin powder for inhalation
|
Indexed keywords
CREATININE;
PLACEBO;
TOBRAMYCIN;
ANTIINFECTIVE AGENT;
POWDER;
ABDOMINAL PAIN;
ACUTE SINUSITIS;
ADOLESCENT;
ADULT;
ARTICLE;
BACTERIAL COUNT;
BRONCHITIS;
BRONCHOSPASM;
CHILD;
COUGHING;
CREATININE BLOOD LEVEL;
CYSTIC FIBROSIS;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPHONIA;
FEMALE;
FEVER;
HEARING IMPAIRMENT;
HEMOPTYSIS;
HUMAN;
LONG TERM CARE;
LUNG ASPERGILLOSIS;
LUNG FUNCTION;
LUNG HEMORRHAGE;
LUNG INFECTION;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE CYCLE TREATMENT;
PHASE 3 CLINICAL TRIAL (TOPIC);
PNEUMONIA;
POLYP;
PRIORITY JOURNAL;
PROTEINURIA;
PSEUDOMONAS INFECTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RESPIRATORY TRACT INFECTION;
SECRETORY OTITIS MEDIA;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
VIRAL RESPIRATORY TRACT INFECTION;
COMPLICATION;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECTS;
INHALATIONAL DRUG ADMINISTRATION;
MICROBIAL SENSITIVITY TEST;
MICROBIOLOGY;
PATHOPHYSIOLOGY;
POWDER;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
RANDOMIZED CONTROLLED TRIAL;
SPUTUM;
TREATMENT OUTCOME;
YOUNG ADULT;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ANTI-BACTERIAL AGENTS;
CHILD;
CYSTIC FIBROSIS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
POWDERS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
SPUTUM;
TOBRAMYCIN;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 84952877731
PISSN: 87556863
EISSN: 10990496
Source Type: Journal
DOI: 10.1002/ppul.23358 Document Type: Article |
Times cited : (17)
|
References (9)
|